Corline Biomedical
15.90 SEK
+3.92 %
Less than 1K followers
CLBIO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Corline Biomedical
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.8 | 2.0 | 9.8 | 2.1 | 2.2 | 1.3 | 2.1 | 7.7 |
| EBITDA | -3.0 | -14.1 | -23.1 | -3.1 | -3.2 | -3.4 | -5.0 | -14.6 |
| EBIT | -3.0 | -14.2 | -23.2 | -3.1 | -3.3 | -3.4 | -5.1 | -14.8 |
| EBIT-% | -168.4 % | -704.0 % | -236.9 % | -149.0 % | -148.9 % | -256.5 % | -240.7 % | -192.8 % |
| Profit before taxes | -3.0 | -14.2 | -23.2 | -3.1 | -3.3 | -3.4 | -5.0 | -14.7 |
| Net income | -3.0 | -14.2 | -23.2 | -3.1 | -3.3 | -3.4 | -5.0 | -14.7 |